Ellen Rohde
Corporate Officer/Principal chez VERVE THERAPEUTICS, INC.
Postes actifs de Ellen Rohde
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| VERVE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/10/2019 | - |
Historique de carrière de Ellen Rohde
Anciens postes connus de Ellen Rohde
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Cerulean Pharma, Inc.
 Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | Corporate Officer/Principal | - | - |
| BIOGEN INC. | Corporate Officer/Principal | - | - |
| INTELLIA THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Formation de Ellen Rohde
| University of Cincinnati (Ohio) | Doctorate Degree |
| Universität Leipzig | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
| Allemagne | 2 |
Opérationnelle
| Corporate Officer/Principal | 4 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| VERVE THERAPEUTICS, INC. | Health Technology |
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | Health Technology |
- Bourse
- Insiders
- Ellen Rohde
- Expérience
